Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BORTEZOMIB [ROUTE CODE "BR"], with a corresponding US DMF Number 27569.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 13, 2015, and payment made on September 23, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II